OrbiMed’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

OrbiMed’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-53,300	Closed	-$2.85M	–	157
2016 Q1	$2.85M	Hold	53,300	–	–	0.03%	125
2015 Q4	$6.02M	Hold	53,300	–	–	0.05%	106
2015 Q3	$6.27M	Sell	53,300 -75,700	-59%	-$9.89M	0.06%	108
2015 Q2	$9.99M	Buy	+129,000	New	+$8.46M	0.08%	106

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

OrbiMed's ANAC Position: Q2 2016 in Review

OrbiMed sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 53,300 shares — an estimated $2.85M sold.

OrbiMed first reported a position in ANAC in Q2 2015 and held it in 4 quarters. The position peaked at $9.99M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

OrbiMed reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
OrbiMed sold 53,300 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.85M.
OrbiMed first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 4 quarters.
OrbiMed's ANACOR PHARMACEUTICALS INC COM position peaked at $9.99M in Q2 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on OrbiMed's 13F filing for Q2 2016, filed 15 Aug 2016.